Literature DB >> 25220477

Elevated dopamine induces minimal hepatic encephalopathy by activation of astrocytic NADPH oxidase and astrocytic protein tyrosine nitration.

Saidan Ding1, Jianjing Yang2, Leping Liu1, Yiru Ye3, Xuebao Wang4, Jiangnan Hu2, Bicheng Chen1, Qichuan Zhuge5.   

Abstract

BACKGROUND: We previously demonstrated that dopamine (DA) overload may be a key mechanism behind development of minimal hepatic encephalopathy (MHE) in rats. It has been shown that low-grade cerebral oedema and oxidative stress play important roles in the pathogenesis of MHE. In the current study, DA-triggered oxidative injury in cerebral cortex was studied.
METHODS: An MHE rat model was used. DA was injected intracerebroventricularly (i.c.v.) into rats and added to primary cortical astrocytes (PCAs). Immunoblotting, immunoprecipitation and immunostaining were conducted after DA injection.
RESULTS: Cognitive impairment and cerebral edema were observed in MHE rats and rats injected with 10 μg DA. Astrocyte swelling was increased by DA. Astrocytic protein tyrosine nitration (PTN) was induced by DA. DA-induced PTN was insensitive to l-NMMA but was blunted by apocynin, superoxide dismutase, catalase and uric acid. Exposure to DA substantially increased levels of astrocytic NADPH oxidase subunits and induced p47(phox) phosphorylation and reactive oxygen species production but decreased the expression and activity of neuronal-type nitric oxide synthase (nNOS).
CONCLUSIONS: PTN induced by DA, which was attributed to NADPH oxidase and not to nNOS, may alter astrocyte function and thereby contribute to the precipitation of MHE episodes.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Dopamine; Minimal hepatic encephalopathy; NADPH oxidase; Protein tyrosine nitration

Mesh:

Substances:

Year:  2014        PMID: 25220477     DOI: 10.1016/j.biocel.2014.09.003

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  6 in total

1.  Dopamine Burden Triggers Neurodegeneration via Production and Release of TNF-α from Astrocytes in Minimal Hepatic Encephalopathy.

Authors:  Saidan Ding; Weikan Wang; Xuebao Wang; Yong Liang; Leping Liu; Yiru Ye; Jianjing Yang; Hongchang Gao; Qichuan Zhuge
Journal:  Mol Neurobiol       Date:  2015-10-03       Impact factor: 5.590

Review 2.  A Mini-Review of the NADPH oxidases in Vascular Dementia: Correlation with NOXs and Risk Factors for VaD.

Authors:  Dong-Hee Choi; Jongmin Lee
Journal:  Int J Mol Sci       Date:  2017-11-22       Impact factor: 5.923

3.  DA Negatively Regulates IGF-I Actions Implicated in Cognitive Function via Interaction of PSD95 and nNOS in Minimal Hepatic Encephalopathy.

Authors:  Saidan Ding; Weishan Zhuge; Xuebao Wang; Jianjing Yang; Yuanshao Lin; Chengde Wang; Jiangnan Hu; Qichuan Zhuge
Journal:  Front Cell Neurosci       Date:  2017-09-06       Impact factor: 5.505

4.  Baicalin reverses the impairment of synaptogenesis induced by dopamine burden via the stimulation of GABAAR-TrkB interaction in minimal hepatic encephalopathy.

Authors:  Saidan Ding; Weishan Zhuge; Jiangnan Hu; Jianjing Yang; Xuebao Wang; Fangfang Wen; Chengde Wang; Qichuan Zhuge
Journal:  Psychopharmacology (Berl)       Date:  2018-02-06       Impact factor: 4.530

Review 5.  Cognition-tracking-based strategies for diagnosis and treatment of minimal hepatic encephalopathy.

Authors:  Weijia Han; Huanqian Zhang; Ying Han; Zhongping Duan
Journal:  Metab Brain Dis       Date:  2020-06-03       Impact factor: 3.584

6.  Hydrogen sulphide ameliorates dopamine-induced astrocytic inflammation and neurodegeneration in minimal hepatic encephalopathy.

Authors:  Weishan Zhuge; Qichuan Zhuge; Weikan Wang; Xiaoai Lu; Ruimin You; Leping Liu; He Yu; Jian Wang; Xuebao Wang; Yiru Ye; Saidan Ding
Journal:  J Cell Mol Med       Date:  2020-10-28       Impact factor: 5.295

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.